Miller Deborah Ann reported option exercise involving 5,500 derivative units of Nuvalent, Inc. at $0.00 for $0 on May 28, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Chief Legal Officer
Chief Legal Officer
Filed Jun 1, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
5,500Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
72,608Direct
Trade date
May 28, 2026Option exercise
Filed
Jun 1, 2026, 4:30 PM ET4-day reporting delay
Accession
0001868741-26-000004Code M · Transaction 388619
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 28, 2026Sell1,401$106.32−$148,954.32Trade 388615
May 28, 2026Sell1,530$107.45−$164,398.50Trade 388616
May 28, 2026Sell900$108.14−$97,326Trade 388617
May 28, 2026Sell1,669$109.30−$182,421.70Trade 388618
May 28, 2026Option exercise5,500$6.89$37,895Trade 388614
6 transaction rows in this filing. Joint filers share the same rows.

NUVL price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
NUVL · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +9.6%1w ago +8.8%1d ago +15%
Returns since7d −4.9%30d +33%90d +33%180d1y

Footnotes in full

F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024. F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.87 to $106.84, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) of this Form 4. F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.87 to $107.80, inclusive. F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.87 to $108.53, inclusive. F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.94 to $109.76, inclusive. F6: The shares underlying this option are fully vested.